Asia Pacific Latent TB Detection Market to Grow at a CAGR of 6.0% to reach US$ 321.81 Million from 2020 to 2027

1. Introduction

1.1 Business Market Insights Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:

4. Asia Pacific Latent TB Detection Market Landscape

4.1 Market Overview

4.2 Porter's Five Forces Analysis

4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes

4.3 Ecosystem Analysis

4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors/Suppliers
4.3.4 End Users

5. Asia Pacific Latent TB Detection Market – Key Market Dynamics

5.1 Growth Drivers

5.1.1 Government Initiatives to Promote Tuberculosis Detection

5.2 Market Opportunities

5.2.1 Advancements in Tuberculosis Diagnosis

5.3 Future Trends

5.3.1 Outsourcing Locations for Tuberculosis Diagnosis

5.4 Impact of Drivers and Restraints

6. Asia Pacific Latent TB Detection Market Regional Analysis

6.1 Asia Pacific Latent TB Detection Market Overview

6.2 Asia Pacific Latent TB Detection Market Revenue 2018-2027 (US$ Million)

6.3 Asia Pacific Latent TB Detection Market Forecast Analysis

7. Asia Pacific Latent TB Detection Market Analysis – by Test

7.1 Tuberculin Skin Test

7.1.1 Overview
7.1.2 Tuberculin Skin Test: Asia Pacific Latent TB Detection Market – Revenue and Forecast to 2031 (US$ Million)

7.2 Interferon Gamma Released Assay

7.2.1 Overview
7.2.2 Interferon Gamma Released Assay: Asia Pacific Latent TB Detection Market – Revenue and Forecast to 2031 (US$ Million)

8. Asia Pacific Latent TB Detection Market Analysis – by End User

8.1 Hospitals

8.1.1 Overview
8.1.2 Hospitals: Asia Pacific Latent TB Detection Market – Revenue and Forecast to 2027 (US$ Million)

8.2 Diagnostic Centers

8.2.1 Overview
8.2.2 Diagnostic Centers: Asia Pacific Latent TB Detection Market – Revenue and Forecast to 2027 (US$ Million)

8.3 Laboratories

8.3.1 Overview
8.3.2 Laboratories: Asia Pacific Latent TB Detection Market – Revenue and Forecast to 2027 (US$ Million)

9. Asia Pacific Latent TB Detection Market – Asia-Pacific Analysis

9.1 Asia-Pacific

9.1.1 Asia Pacific Latent TB Detection Market Breakdown, by Key Country, 2021 and 2027 (%)
9.1.1.1 Asia Pacific Latent TB Detection Market – Revenue and Forecast Analysis – by Country
9.1.1.1 China: Asia Pacific Latent TB Detection Market – Revenue and Forecast to 2027 (US$ Million)

9.1.1.1.1 China: Asia Pacific Latent TB Detection Market Breakdown, by Test
9.1.1.1.2 China: Asia Pacific Latent TB Detection Market Breakdown, by End User

9.1.1.2 India: Asia Pacific Latent TB Detection Market – Revenue and Forecast to 2027 (US$ Million)

9.1.1.2.1 India: Asia Pacific Latent TB Detection Market Breakdown, by Test
9.1.1.2.2 India: Asia Pacific Latent TB Detection Market Breakdown, by End User

9.1.1.3 Japan: Asia Pacific Latent TB Detection Market – Revenue and Forecast to 2027 (US$ Million)

9.1.1.3.1 Japan: Asia Pacific Latent TB Detection Market Breakdown, by Test
9.1.1.3.2 Japan: Asia Pacific Latent TB Detection Market Breakdown, by End User

9.1.1.4 Australia: Asia Pacific Latent TB Detection Market – Revenue and Forecast to 2027 (US$ Million)

9.1.1.4.1 Australia: Asia Pacific Latent TB Detection Market Breakdown, by Test
9.1.1.4.2 Australia: Asia Pacific Latent TB Detection Market Breakdown, by End User

9.1.1.5 Rest of Asia-Pacific : Asia Pacific Latent TB Detection Market – Revenue and Forecast to 2027 (US$ Million)

9.1.1.5.1 Rest of Asia-Pacific : Asia Pacific Latent TB Detection Market Breakdown, by Test
9.1.1.5.2 Rest of Asia-Pacific : Asia Pacific Latent TB Detection Market Breakdown, by End User

10. Competitive Landscape

10.1 Heat Map Analysis

10.2 Company Positioning and Concentration

11. Asia Pacific Latent TB Detection Market Industry Landscape

11.1 Overview

11.2 Mergers and Acquisitions

11.3 Agreements, Collaborations, and Joint Ventures

11.4 New Product Launches

11.5 Expansions and Other Strategic Developments

12. Company Profiles

12.1 Abbott

12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments

12.2 ARKRAY, Inc.

12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments

12.3 BD

12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments

12.4 bioMerieux SA

12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments

12.5 F. HOFFMANN-LA ROCHE LTD.

12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments

12.6 Lionex GmbH

12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments

12.7 Oxford Immunotec Ltd

12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments

12.8 QIAGEN

12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments

12.9 Serum Institute of India Pvt. Ltd.

12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments

13. Appendix

13.1 About Business Market Insights